UPDATE: Piper Sandler Downgrades Global Blood Therapeutics (GBT) to Neutral
Tweet Send to a Friend
(Updated - January 20, 2021 9:24 AM EST)
Piper Sandler analyst Joseph Catanzaro downgraded Global Blood Therapeutics (NASDAQ: GBT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Joseph Catanzaro downgraded Global Blood Therapeutics (NASDAQ: GBT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
